Sign in Join
Daily desk

News

Artificial intelligence, technology, science, health and education — reported daily, with the original source attached to every item.

Showing articles about prevnar 20 capvaxive comparison

1 story

A shield icon ringed by 31 serotype dots (two amber) illustrates VAX-31 clearing nearly all Phase 3 goals in the 4,047-adult OPUS-1 trial.
🩺 Health Report

Vaxcyte's VAX-31 Matches All Phase 3 Topline Goals; Two Serotypes Miss Strict Bar vs Capvaxive

Vaxcyte's OPUS-1 Phase 3 trial of VAX-31 met all primary endpoints: non-inferiority on all 28 shared serotypes and superiority on the rest,…

EduFabTech · 2h ago · 4 min read